Trial site
Zhongshan Hospital Affiliated to Fudan University
- 28running trials
- 14closed trials
The trials here
What the 42 trials at this site are about, from their registry records.
- Conditions
- Liver and biliary tract cancer7 trials
- Heart failure5 trials
- Obesity5 trials
- Bronchiectasis3 trials
- Lung cancer3 trials
- Pancreatic cancer3 trials
- Chronic kidney disease2 trials
- COPD2 trials
- Gastric and oesophageal cancer2 trials
- Idiopathic pulmonary fibrosis2 trials
- Sarcoma2 trials
- Type 2 diabetes2 trials
- and 12 more
- Phase
- Phase 315 trials
- Phase 211 trials
- Phase 17 trials
- Early phase 11 trial
- Phase 1/21 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Recruiting12 trials
- Completed11 trials
- Active, not recruiting9 trials
- Not yet recruiting7 trials
- Terminated3 trials
- Lead sponsor
- Boehringer Ingelheim12 trials
- Shanghai Zhongshan Hospital4 trials
- Jiangsu HengRui Medicine Co., Ltd.2 trials
- Shandong Suncadia Medicine Co., Ltd.2 trials
- Shanghai Junshi Bioscience Co., Ltd.2 trials
- and 20 more
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer
Recruiting
Recruiting
Active, not recruiting
A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE
Recruiting
A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer
Active, not recruiting
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Recruiting
JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma
Recruiting
Active, not recruiting
Recruiting
HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders
Recruiting
Active, not recruiting
A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC
Active, not recruiting
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell Lymphoma
Active, not recruiting
Recruiting
Not yet recruiting
PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure4 recruiting
- Liver and biliary tract cancer4 recruiting
- Pancreatic cancer3 recruiting
- Bronchiectasis2 recruiting
- Obesity2 recruiting
- ANCA-associated vasculitis1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Gastric and oesophageal cancer1 recruiting
- IgA nephropathy1 recruiting
- Kidney cancer1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
A Study of IBI3032 in Chinese Healthy Participants and Participants With Overweight or Obesity
Completed
To Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or Obese
Completed
Evaluation of 611 in Chinese Adults With Moderate to Severe Chronic Obstructive Pulmonary Disease
Completed
Completed
A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis
Completed
Completed
Terminated
A Study of ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors
Terminated
Completed
Terminated
CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive Sarcomas
Completed
Completed
Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026